Journal
BRITISH JOURNAL OF HAEMATOLOGY
Volume 143, Issue 2, Pages 240-247Publisher
WILEY-BLACKWELL
DOI: 10.1111/j.1365-2141.2008.07348.x
Keywords
chronic lymphocytic leukaemia; deuterium glucose; gas chromatography mass spectrometry; B lymphocytes; turnover rate
Categories
Funding
- European Union [INCA LSHC-CT-2005-018704]
- Belgian Foundation against Cancer
- Bekales Foundation
- Fonds National de la Recherche Scientifique (FNRS)
- MRC [G0601072] Funding Source: UKRI
Ask authors/readers for more resources
Whether chronic lymphocytic leukaemia (CLL) is a latent or a proliferating disease has been intensively debated. Whilst the dogma that CLL results from accumulation of dormant lymphocytes is supported by the unresponsiveness of leukaemic cells to antigens and polyclonal activators, recent in vivo kinetic measurements indicate that B lymphocytes do divide at significant rates in CLL. However, an important and still unanswered question is whether CLL cells proliferate faster or slower compared with their normal counterparts. This report addressed directly this point and compared B-cell kinetics in CLL subjects and healthy controls, using a pulse-chase approach based on incorporation of deuterium from 6,6-H-2(2)-glucose into DNA. We confirmed that B cells proliferated at significant levels in CLL but found that the proliferation rates were reduced compared with healthy subjects (mean 0.47 vs. 1.31%/d respectively, P = 0.007), equivalent to an extended doubling time of circulating B cells (147 d vs. 53 d). In conclusion, CLL B cells proliferate at reduced levels compared with healthy controls. CLL is thus characterized by an aberrant B-cell kinetics with a decrease in cell turnover, an observation that may impact on elaboration of efficient therapeutic strategies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available